| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.09e-06 | 105 | 112 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC38A10 SLC16A4 SLC38A11 CTNS SLC38A6 | 2.54e-06 | 207 | 112 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC38A10 SLC16A4 SLC38A11 CTNS SLC38A6 | 2.64e-06 | 208 | 112 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | disaccharide binding | 5.91e-06 | 7 | 112 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A18 SLC9A9 SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC16A4 SLC2A13 CTNS SLC29A1 | 6.57e-06 | 296 | 112 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | galactoside binding | 1.41e-05 | 9 | 112 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | symporter activity | 2.20e-05 | 150 | 112 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC38A10 SLC16A4 SLC38A11 CTNS SLC38A6 | 4.09e-05 | 293 | 112 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 4.92e-05 | 71 | 112 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 SLC9A9 SLC26A4 SLC10A7 SLC7A8 SLC6A13 ATP8A1 SLC16A4 SLC2A13 CTNS SLC29A1 | 7.72e-05 | 477 | 112 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | uracil transmembrane transporter activity | 9.32e-05 | 3 | 112 | 2 | GO:0015210 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 SLC9A9 SLC26A4 SLC10A7 SLC29A2 SLC7A8 SLC6A13 SLC38A10 ATP8A1 SLC16A4 CNGB3 SLC35F6 SV2C SLC2A13 SLC38A11 CTNS SLC29A1 SLC38A6 | 9.69e-05 | 1180 | 112 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.83e-04 | 20 | 112 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.83e-04 | 20 | 112 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | cytidine transmembrane transporter activity | 1.86e-04 | 4 | 112 | 2 | GO:0015212 | |
| GeneOntologyMolecularFunction | purine nucleoside transmembrane transporter activity | 1.86e-04 | 4 | 112 | 2 | GO:0015211 | |
| GeneOntologyMolecularFunction | guanine transmembrane transporter activity | 1.86e-04 | 4 | 112 | 2 | GO:0015208 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 SLC9A9 SLC26A4 SLC10A7 SLC29A2 SLC7A8 SLC6A13 SLC38A10 ATP8A1 SLC16A4 CNGB3 SLC35F6 SV2C SLC2A13 SLC38A11 CTNS SLC29A1 SLC38A6 | 2.90e-04 | 1289 | 112 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.98e-04 | 301 | 112 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 3.08e-04 | 5 | 112 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | enzyme activator activity | LGALS9C RANBP2 RGPD8 LGALS9B ITSN1 RGPD1 TOPBP1 CLPX DDOST LGALS9 LLGL2 RGPD5 | 3.15e-04 | 656 | 112 | 12 | GO:0008047 |
| GeneOntologyMolecularFunction | uridine transmembrane transporter activity | 4.61e-04 | 6 | 112 | 2 | GO:0015213 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.58e-04 | 119 | 112 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | pyrimidine nucleobase transmembrane transporter activity | 6.43e-04 | 7 | 112 | 2 | GO:0005350 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 8.54e-04 | 8 | 112 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 9.72e-04 | 78 | 112 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.07e-03 | 36 | 112 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.36e-03 | 10 | 112 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | nucleoside transmembrane transporter activity | 1.36e-03 | 10 | 112 | 2 | GO:0005337 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.57e-03 | 41 | 112 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.66e-03 | 11 | 112 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | kinase activator activity | 2.03e-03 | 159 | 112 | 5 | GO:0019209 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 2.78e-03 | 50 | 112 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 3.28e-03 | 53 | 112 | 3 | GO:0016859 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides | 3.55e-03 | 16 | 112 | 2 | GO:0016812 | |
| GeneOntologyMolecularFunction | molecular function activator activity | LGALS9C RANBP2 RGPD8 LGALS9B ITSN1 RGPD1 TOPBP1 CLPX DDOST LGALS9 TG BMP1 BMP4 LLGL2 RGPD5 | 3.70e-03 | 1233 | 112 | 15 | GO:0140677 |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 4.01e-03 | 17 | 112 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 4.01e-03 | 17 | 112 | 2 | GO:0070742 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.38e-07 | 4 | 113 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.87e-06 | 20 | 113 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 8.33e-06 | 87 | 113 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 8.79e-06 | 8 | 113 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | vascular transport | 8.90e-06 | 88 | 113 | 6 | GO:0010232 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.21e-05 | 195 | 113 | 8 | GO:0006865 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.31e-05 | 9 | 113 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | EPRS1 SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC38A10 LLGL2 SLC16A4 SLC38A11 CTNS SLC38A6 | 1.58e-05 | 410 | 113 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | EPRS1 SLC26A4 SLC10A7 SLC7A8 SLC6A13 SLC38A10 LLGL2 SLC16A4 SLC38A11 CTNS SLC38A6 | 1.66e-05 | 412 | 113 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.87e-05 | 10 | 113 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.94e-05 | 60 | 113 | 5 | GO:0015804 | |
| GeneOntologyBiologicalProcess | organic anion transport | EPRS1 SLC26A4 SLC10A7 PTGER3 SLC7A8 SLC6A13 SLC38A10 LLGL2 SLC16A4 SLC38A11 CTNS SLC38A6 | 2.59e-05 | 515 | 113 | 12 | GO:0015711 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.87e-05 | 108 | 113 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | thymine transport | 2.98e-05 | 2 | 113 | 2 | GO:0035364 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.40e-05 | 13 | 113 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 4.91e-05 | 37 | 113 | 4 | GO:0033081 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 5.20e-05 | 120 | 113 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.58e-05 | 14 | 113 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 6.94e-05 | 15 | 113 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 6.94e-05 | 15 | 113 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | uracil transmembrane transport | 8.89e-05 | 3 | 113 | 2 | GO:1903791 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transmembrane transport | 8.89e-05 | 3 | 113 | 2 | GO:1904082 | |
| GeneOntologyBiologicalProcess | uracil transport | 8.89e-05 | 3 | 113 | 2 | GO:0015857 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 8.94e-05 | 43 | 113 | 4 | GO:0060391 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.03e-04 | 17 | 113 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 1.17e-04 | 46 | 113 | 4 | GO:0051353 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.23e-04 | 18 | 113 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.46e-04 | 19 | 113 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.46e-04 | 19 | 113 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.71e-04 | 20 | 113 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | guanine transmembrane transport | 1.77e-04 | 4 | 113 | 2 | GO:1903716 | |
| GeneOntologyBiologicalProcess | hypoxanthine transport | 1.77e-04 | 4 | 113 | 2 | GO:0035344 | |
| GeneOntologyBiologicalProcess | inosine transport | 1.77e-04 | 4 | 113 | 2 | GO:0035340 | |
| GeneOntologyBiologicalProcess | cytidine transport | 1.77e-04 | 4 | 113 | 2 | GO:0015861 | |
| GeneOntologyBiologicalProcess | guanine transport | 1.77e-04 | 4 | 113 | 2 | GO:0015854 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.98e-04 | 21 | 113 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | adenosine transport | 2.94e-04 | 5 | 113 | 2 | GO:0032238 | |
| GeneOntologyBiologicalProcess | purine nucleoside transmembrane transport | 2.94e-04 | 5 | 113 | 2 | GO:0015860 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 3.80e-04 | 26 | 113 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside transport | 4.40e-04 | 6 | 113 | 2 | GO:0015864 | |
| GeneOntologyBiologicalProcess | uridine transmembrane transport | 4.40e-04 | 6 | 113 | 2 | GO:0015862 | |
| GeneOntologyBiologicalProcess | adenine transport | 4.40e-04 | 6 | 113 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.48e-04 | 249 | 113 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 4.75e-04 | 28 | 113 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 5.84e-04 | 30 | 113 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase transport | 6.14e-04 | 7 | 113 | 2 | GO:0015855 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.44e-04 | 31 | 113 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 6.44e-04 | 31 | 113 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 7.07e-04 | 32 | 113 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 7.75e-04 | 33 | 113 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | nucleoside transmembrane transport | 8.15e-04 | 8 | 113 | 2 | GO:1901642 | |
| GeneOntologyBiologicalProcess | purine nucleobase transmembrane transport | 8.15e-04 | 8 | 113 | 2 | GO:1904823 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 8.67e-06 | 8 | 114 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.84e-05 | 10 | 114 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 5.50e-05 | 14 | 114 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.21e-04 | 18 | 114 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | cell projection membrane | SLC6A18 TCTN3 PSD2 SLC26A4 TSPEAR PTGER3 SLC7A8 GPR157 SCARB1 CSPG4 | 1.26e-04 | 431 | 114 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.68e-04 | 20 | 114 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.96e-04 | 21 | 114 | 3 | GO:0106068 | |
| Domain | Ran_BP1 | 5.64e-07 | 12 | 111 | 4 | PF00638 | |
| Domain | RANBD1 | 5.64e-07 | 12 | 111 | 4 | PS50196 | |
| Domain | RanBD | 8.11e-07 | 13 | 111 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 8.11e-07 | 13 | 111 | 4 | IPR000156 | |
| Domain | Grip | 3.26e-05 | 11 | 111 | 3 | SM00755 | |
| Domain | GRIP | 3.26e-05 | 11 | 111 | 3 | PF01465 | |
| Domain | GRIP_dom | 4.32e-05 | 12 | 111 | 3 | IPR000237 | |
| Domain | GRIP | 4.32e-05 | 12 | 111 | 3 | PS50913 | |
| Domain | Galectin_CRD | 8.82e-05 | 15 | 111 | 3 | IPR001079 | |
| Domain | Gal-bind_lectin | 8.82e-05 | 15 | 111 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 8.82e-05 | 15 | 111 | 3 | SM00908 | |
| Domain | GALECTIN | 8.82e-05 | 15 | 111 | 3 | PS51304 | |
| Domain | GLECT | 8.82e-05 | 15 | 111 | 3 | SM00276 | |
| Domain | Aa_trans | 1.31e-04 | 17 | 111 | 3 | PF01490 | |
| Domain | AA_transpt_TM | 1.31e-04 | 17 | 111 | 3 | IPR013057 | |
| Domain | Nucleoside_tran | 2.08e-04 | 4 | 111 | 2 | PF01733 | |
| Domain | GPR107-like | 2.08e-04 | 4 | 111 | 2 | IPR009637 | |
| Domain | Lung_7-TM_R | 2.08e-04 | 4 | 111 | 2 | PF06814 | |
| Domain | Eqnu_transpt | 2.08e-04 | 4 | 111 | 2 | IPR002259 | |
| Domain | Rab_bind | 7.21e-04 | 7 | 111 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 7.21e-04 | 7 | 111 | 2 | IPR032023 | |
| Domain | MFS_dom | 1.23e-03 | 134 | 111 | 5 | IPR020846 | |
| Domain | - | 1.53e-03 | 10 | 111 | 2 | 1.10.220.60 | |
| Domain | aa-tRNA-synt_IIb | 1.86e-03 | 11 | 111 | 2 | IPR002314 | |
| Domain | - | 1.86e-03 | 11 | 111 | 2 | 3.40.50.800 | |
| Domain | tRNA-synt_2b | 1.86e-03 | 11 | 111 | 2 | PF00587 | |
| Domain | ConA-like_dom | 1.98e-03 | 219 | 111 | 6 | IPR013320 | |
| Domain | TPR-contain_dom | 2.02e-03 | 150 | 111 | 5 | IPR013026 | |
| Domain | TPR_1 | 2.04e-03 | 90 | 111 | 4 | IPR001440 | |
| Domain | TPR_1 | 2.04e-03 | 90 | 111 | 4 | PF00515 | |
| Domain | LamG | 2.27e-03 | 44 | 111 | 3 | SM00282 | |
| Domain | - | 2.48e-03 | 95 | 111 | 4 | 2.60.120.200 | |
| Domain | Anticodon-bd | 3.04e-03 | 14 | 111 | 2 | IPR004154 | |
| Domain | TPR_REGION | 3.06e-03 | 165 | 111 | 5 | PS50293 | |
| Domain | TPR | 3.06e-03 | 165 | 111 | 5 | PS50005 | |
| Domain | PH_dom-like | 3.92e-03 | 426 | 111 | 8 | IPR011993 | |
| Domain | ATPase_AAA_core | 4.07e-03 | 54 | 111 | 3 | IPR003959 | |
| Domain | Laminin_G | 4.97e-03 | 58 | 111 | 3 | IPR001791 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 5.03e-03 | 18 | 111 | 2 | PS00754 | |
| Domain | - | 5.03e-03 | 18 | 111 | 2 | 3.30.470.20 | |
| Domain | aa-tRNA-synth_II | 5.03e-03 | 18 | 111 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 5.03e-03 | 18 | 111 | 2 | PS50862 | |
| Domain | SNF | 5.60e-03 | 19 | 111 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 5.60e-03 | 19 | 111 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 5.60e-03 | 19 | 111 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 5.60e-03 | 19 | 111 | 2 | PS50267 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC9A9 SLC26A4 SLC29A2 SLC7A8 SLC6A13 SLC2A13 CTNS SLC29A1 | 8.69e-06 | 238 | 81 | 9 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC9A9 SLC26A4 SLC29A2 SLC7A8 SLC6A13 SLC2A13 CTNS SLC29A1 | 1.25e-05 | 249 | 81 | 9 | M5988 |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 5.62e-05 | 117 | 81 | 6 | MM15387 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.40e-04 | 18 | 81 | 3 | MM1549 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.61e-04 | 271 | 81 | 8 | MM15388 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.72e-04 | 100 | 81 | 5 | MM14561 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.88e-04 | 108 | 81 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 4.05e-04 | 109 | 81 | 5 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 SLC9A9 SLC26A4 SLC29A2 SLC7A8 BMP1 SLC6A13 ATP8A1 SCARB1 SLC2A13 CTNS SLC29A1 | 4.85e-04 | 681 | 81 | 12 | MM14985 |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19776007 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 33316546 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9038233 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 28704475 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.43e-08 | 3 | 114 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.43e-08 | 3 | 114 | 3 | 22341088 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 32380082 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23667648 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 28877989 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 19800850 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 38987795 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 37105392 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 36479526 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.43e-08 | 3 | 114 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.43e-08 | 3 | 114 | 3 | 33923930 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.43e-08 | 3 | 114 | 3 | 31969388 | |
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.43e-08 | 3 | 114 | 3 | 35241678 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 22627368 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 33153471 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 22052881 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.43e-08 | 3 | 114 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.43e-08 | 3 | 114 | 3 | 29458010 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 26582205 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 9153289 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 18974023 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.43e-08 | 3 | 114 | 3 | 29651447 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 21146220 | ||
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.43e-08 | 3 | 114 | 3 | 28990062 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 18579572 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 16990264 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 18005988 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 23585851 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.43e-08 | 3 | 114 | 3 | 29433546 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.43e-08 | 3 | 114 | 3 | 25898318 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 31937306 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 21426359 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 18282810 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 24083426 | ||
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.43e-08 | 3 | 114 | 3 | 25931247 | |
| Pubmed | 3.43e-08 | 3 | 114 | 3 | 17560833 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 38686388 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 22677125 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 19234217 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 35715604 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.37e-07 | 4 | 114 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.37e-07 | 4 | 114 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.37e-07 | 4 | 114 | 3 | 33727589 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 25578313 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 18826117 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 38853593 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.37e-07 | 4 | 114 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.37e-07 | 4 | 114 | 3 | 18346632 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 19670381 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.37e-07 | 4 | 114 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.37e-07 | 4 | 114 | 3 | 34369876 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 33203936 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.37e-07 | 4 | 114 | 3 | 33963043 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 33107565 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 30763585 | ||
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.37e-07 | 4 | 114 | 3 | 19362679 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.37e-07 | 4 | 114 | 3 | 20463811 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.37e-07 | 4 | 114 | 3 | 23657851 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 24333756 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.37e-07 | 4 | 114 | 3 | 24958847 | |
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 9480752 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 30120235 | ||
| Pubmed | 1.37e-07 | 4 | 114 | 3 | 11839756 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.37e-07 | 4 | 114 | 3 | 22021615 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 3.41e-07 | 5 | 114 | 3 | 34847625 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 25158758 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 26278059 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 21385853 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 29242193 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 22469568 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 3.41e-07 | 5 | 114 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 3.41e-07 | 5 | 114 | 3 | 9566950 | |
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 37352334 | ||
| Pubmed | 3.41e-07 | 5 | 114 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 3.41e-07 | 5 | 114 | 3 | 37884694 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 6.81e-07 | 6 | 114 | 3 | 20937702 | |
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 8674632 | ||
| Pubmed | 6.81e-07 | 6 | 114 | 3 | 23296703 | ||
| Pubmed | 7.65e-07 | 22 | 114 | 4 | 27717094 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 7.71e-07 | 153 | 114 | 7 | 26365490 | |
| Pubmed | EPRS1 RANBP2 CAD TOPBP1 GRB10 HUWE1 THOC2 ZXDA PAICS MKI67 TMEM131 | 8.75e-07 | 503 | 114 | 11 | 16964243 | |
| Pubmed | 1.19e-06 | 7 | 114 | 3 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.19e-06 | 7 | 114 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.19e-06 | 7 | 114 | 3 | 11353387 | |
| Interaction | NPIPB6 interactions | 2.01e-06 | 18 | 105 | 4 | int:NPIPB6 | |
| Interaction | RGPD4 interactions | 4.73e-06 | 22 | 105 | 4 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.11e-05 | 27 | 105 | 4 | int:RGPD2 | |
| GeneFamily | Solute carriers | SLC6A18 SLC9A9 SLC26A4 SLC10A7 SLC29A2 SLC7A8 SLC6A13 SLC38A10 SLC16A4 SLC2A13 SLC38A11 SLC29A1 SLC38A6 | 2.08e-08 | 395 | 81 | 13 | 752 |
| GeneFamily | 7TM orphan receptors | 1.72e-06 | 6 | 81 | 3 | 310 | |
| GeneFamily | Galectins | 3.79e-05 | 15 | 81 | 3 | 629 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.66e-04 | 115 | 81 | 5 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.56e-04 | 36 | 81 | 3 | 823 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.06e-03 | 11 | 81 | 2 | 455 | |
| GeneFamily | AAA ATPases | 1.73e-03 | 53 | 81 | 3 | 413 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.94e-07 | 193 | 112 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-07 | 193 | 112 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-07 | 193 | 112 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-07 | 194 | 112 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.54e-07 | 200 | 112 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-06 | 173 | 112 | 6 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.06e-06 | 173 | 112 | 6 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.06e-06 | 173 | 112 | 6 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.40e-06 | 175 | 112 | 6 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 5.40e-06 | 175 | 112 | 6 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 178 | 112 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.77e-06 | 182 | 112 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.66e-06 | 186 | 112 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.14e-06 | 188 | 112 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-06 | 189 | 112 | 6 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.39e-06 | 189 | 112 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-06 | 190 | 112 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.18e-06 | 192 | 112 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.18e-06 | 192 | 112 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-06 | 194 | 112 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.06e-05 | 197 | 112 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.13e-05 | 199 | 112 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 112 | 6 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-05 | 200 | 112 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-05 | 147 | 112 | 5 | b2196046656157d7fcf5b5d1cec7bf521b1e5d8e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.12e-05 | 159 | 112 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.65e-05 | 168 | 112 | 5 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 7.23e-05 | 171 | 112 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.23e-05 | 171 | 112 | 5 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-05 | 171 | 112 | 5 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 7.43e-05 | 172 | 112 | 5 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.43e-05 | 172 | 112 | 5 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.63e-05 | 173 | 112 | 5 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.84e-05 | 174 | 112 | 5 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-05 | 175 | 112 | 5 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-05 | 176 | 112 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-05 | 176 | 112 | 5 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.28e-05 | 176 | 112 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.50e-05 | 177 | 112 | 5 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-05 | 177 | 112 | 5 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.73e-05 | 178 | 112 | 5 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.96e-05 | 179 | 112 | 5 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.96e-05 | 179 | 112 | 5 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.20e-05 | 180 | 112 | 5 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | fa819df81fca95c2cc602fede635cb03e3f35fad | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.20e-05 | 180 | 112 | 5 | 907cd510fd2e21532ce04ba687e8894f7af71f27 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 9.44e-05 | 181 | 112 | 5 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 181 | 112 | 5 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-05 | 181 | 112 | 5 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 9.69e-05 | 182 | 112 | 5 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.69e-05 | 182 | 112 | 5 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.94e-05 | 183 | 112 | 5 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.94e-05 | 183 | 112 | 5 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.05e-04 | 185 | 112 | 5 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.05e-04 | 185 | 112 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 185 | 112 | 5 | eb78614c4acf8d2ce7874d7e51e16997b76127ef | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 185 | 112 | 5 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 185 | 112 | 5 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 1.05e-04 | 185 | 112 | 5 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 185 | 112 | 5 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.07e-04 | 186 | 112 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 186 | 112 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 112 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-04 | 188 | 112 | 5 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 189 | 112 | 5 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 189 | 112 | 5 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 189 | 112 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 189 | 112 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 189 | 112 | 5 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 190 | 112 | 5 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | TCGA-Kidney-Primary_Tumor|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.19e-04 | 190 | 112 | 5 | 773c4575d22483d89a54c8db0e09905deed0d088 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.19e-04 | 190 | 112 | 5 | e3696e7542424c03d0a41136b10729a3dd09549a | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-04 | 190 | 112 | 5 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-04 | 190 | 112 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 190 | 112 | 5 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 192 | 112 | 5 | 0b506fb5bca54a50949932293c6f86d974a3acdd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 192 | 112 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 192 | 112 | 5 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 193 | 112 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 193 | 112 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Healthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2) | 1.31e-04 | 194 | 112 | 5 | bf2e889de60b2b452a41f4d59a0f2a1865f07184 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.31e-04 | 194 | 112 | 5 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 194 | 112 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 194 | 112 | 5 | 297286c57d7ee6338d9cf77b27eb2809378ce15d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-04 | 194 | 112 | 5 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 195 | 112 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Healthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class | 1.34e-04 | 195 | 112 | 5 | f4955c176c4918052dc151c5e5249223ec428272 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 1.34e-04 | 195 | 112 | 5 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 196 | 112 | 5 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 196 | 112 | 5 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Healthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2) | 1.37e-04 | 196 | 112 | 5 | b04684d319d0c462862677d0f956a389bffef535 | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 1.37e-04 | 196 | 112 | 5 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 197 | 112 | 5 | 902e2ce011a938c1de39ff53ebbb2ec5557e48bc | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 197 | 112 | 5 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-04 | 197 | 112 | 5 | 3b08b190b7d4ddd4c66a5b6015df777fc2f6f9e3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 197 | 112 | 5 | 836fcb20d3a1f9cf14f6fd505fbb6bad4650fd28 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD8+_Tem|COVID-19_Mild / Disease group, lineage and cell class | 1.40e-04 | 197 | 112 | 5 | 1b1983f74ce568f8c032a1d1b68a512ef026ba9f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-04 | 197 | 112 | 5 | adb8c21351ae1cf3d834b3dc8a8da512cb0ea68b | |
| Disease | goiter (is_implicated_in) | 1.25e-05 | 2 | 105 | 2 | DOID:12176 (is_implicated_in) | |
| Disease | Achromatopsia | 2.60e-04 | 7 | 105 | 2 | C0152200 | |
| Disease | Goiter | 2.60e-04 | 7 | 105 | 2 | C0018021 | |
| Disease | FEV/FEC ratio | COL6A3 RFX6 CEMIP2 TG BMP4 PPARGC1B LLGL2 ANAPC1 GPR157 CSPG4 LEPROTL1 CSMD1 HOMER2 | 4.22e-04 | 1228 | 105 | 13 | EFO_0004713 |
| Disease | tooth agenesis (is_implicated_in) | 5.54e-04 | 10 | 105 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | Barrett's esophagus (is_marker_for) | 6.76e-04 | 11 | 105 | 2 | DOID:9206 (is_marker_for) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.06e-03 | 19 | 105 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | bone density | 2.68e-03 | 388 | 105 | 6 | EFO_0003923 | |
| Disease | QRS duration, response to sulfonylurea | 3.02e-03 | 23 | 105 | 2 | EFO_0005055, EFO_0007922 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLFGNFTAQLRFISD | 1011 | Q96PZ7 | |
| FVANGSSVAGIFQLS | 1906 | Q6UVK1 | |
| QSFLFQGRDGATSFS | 471 | Q8N5R6 | |
| DTTNILFVASGAFNG | 411 | O76031 | |
| FFQFLGNLFNISGKS | 121 | Q68DQ2 | |
| NLKGSFSNASGLFEI | 1511 | Q9P2K8 | |
| FENSFGNLSFGTLLD | 311 | P51816 | |
| LGAFDSTIFQSLNFG | 216 | Q99467 | |
| SDGSINKAGFAVNFF | 531 | P13497 | |
| GTSENSAFRFLFNLS | 131 | P12644 | |
| GASNFGLNFLTFIIL | 336 | Q9Y2Q0 | |
| NLFRFGESTTGFNFS | 2256 | P49792 | |
| FLNTGSFNFLSNTGA | 771 | Q8HWS3 | |
| NSSATGSLFGFSFNA | 1561 | Q99666 | |
| NSSATGSLFGFSFNA | 1561 | O14715 | |
| GGAVSFQFFFNISTD | 201 | Q5VW38 | |
| NGSLFTSSRLFFAGA | 331 | Q9UHI5 | |
| SLGFRFAGSENLSAF | 1471 | Q9H1A4 | |
| NEAAAIFNSAFGSFL | 131 | Q0GE19 | |
| TFQSFVFLGGQLTLA | 156 | Q96H96 | |
| GQQTAFDFTSRVIGF | 321 | Q6P1M3 | |
| ESTFGVGNFNAFKST | 241 | Q86WP2 | |
| AVDFQTGFSGNDIAF | 46 | Q6DKI2 | |
| FGLGFSSEQQLTKFA | 86 | Q9NSB8 | |
| AVDFQTGFSGNDIAF | 46 | Q3B8N2 | |
| AVNFQTGFSGNDIAF | 46 | O00182 | |
| AGATSEGVLANFFNS | 436 | Q9Y6G9 | |
| LSNGGQFTIVFFKDA | 76 | Q5H9U9 | |
| VSGSFLQLAYQGSDF | 126 | P06126 | |
| SSVGNIFLSAAFQFS | 221 | Q9Y256 | |
| LFGFGASIFSQASNL | 931 | Q9Y6V0 | |
| SGLFFGNNSISFQSC | 81 | Q6IF82 | |
| GNLFFASAFAFLGLL | 226 | P43115 | |
| FVGQSFIFGVTNFEN | 121 | Q8IXT1 | |
| GLSQFSLSALDQFAG | 71 | A1E959 | |
| ATILGFFLVFGSNDD | 111 | O95214 | |
| TSESFGGNVFFSAQN | 801 | P46013 | |
| NASSEDFFILLGFSN | 6 | O76002 | |
| NNARVIFSGSLDFFS | 251 | P39656 | |
| GFSINSQVFAADGAS | 2006 | Q7Z6Z7 | |
| DFVFLGFSSSGELQL | 11 | Q8NGY1 | |
| QTLGGDFFLLGIFSQ | 6 | Q8NGZ9 | |
| QGQTSDVFFAAGSLT | 501 | O43422 | |
| GFASAFSSNFNSALV | 836 | Q86XN7 | |
| AFLASFQALGSEGQE | 276 | Q96JP2 | |
| SFDGADQGLLNSFFR | 191 | O15488 | |
| GFSATSEIQFILFGL | 16 | O76099 | |
| FGFSGLNVKAFISNV | 746 | Q14008 | |
| EGTFSLAGFQDFTFL | 11 | Q9BV87 | |
| SESGLFLFQASNSLF | 146 | Q86TI2 | |
| FLEAFGFDNTGTFQV | 1906 | A8TX70 | |
| SGFITGDQARNFFFQ | 36 | Q15811 | |
| AFQRASSFSLAGIGF | 386 | Q5VZB9 | |
| QASVFSFGLGAQAAS | 371 | P12111 | |
| SGFFFTQAFLTGAQQ | 3876 | Q8WXX0 | |
| LQGALSTFANTSSFF | 81 | Q5UAW9 | |
| VQNSAFADNGIGLTF | 796 | Q9UHN6 | |
| SASSNISGGIFLFFV | 36 | P31358 | |
| FGFSNEFTVGNKLDT | 201 | Q9P0L2 | |
| GQTFFSLDDGNTKFS | 551 | Q13322 | |
| LAIAFGANNLTFTGT | 1566 | Q05BV3 | |
| IGLSFDFVALNLTGF | 156 | O60931 | |
| IAQLDTGDFSTAFFN | 466 | P54198 | |
| DLGSNFFARLFGFQV | 106 | Q9HBR0 | |
| VIANVFFGGNLSSVF | 266 | Q08AI6 | |
| SSNLDLNFEISFGGI | 301 | Q96NU0 | |
| NSSATGSLFGFSFNA | 1546 | P0DJD0 | |
| SDLFFGNNSISFQSF | 81 | Q8NGN8 | |
| INTLFITGGQFFASV | 211 | Q96QE2 | |
| FGQLGLGTFLFETSE | 271 | Q92834 | |
| NSRTQGFLALFSGDT | 251 | Q9Y230 | |
| AFVLGNFSNGFIALV | 16 | P0DSN6 | |
| AFVLGNFSNGFIALV | 16 | P0DTE0 | |
| LLFGGQFASSQETYG | 31 | Q7Z4G4 | |
| FGFLEAQQAFQSVGT | 151 | P07814 | |
| FINSFSAVLQGSLFG | 136 | Q14542 | |
| SVNGFFAFLSSFVQG | 226 | Q496J9 | |
| FDAAAFFQSVGNFLG | 266 | Q8IVB4 | |
| TAFSFGSLLAVFGNL | 36 | Q969N4 | |
| QISLSQGSAVFDFSG | 1001 | O14841 | |
| DIQLNSFGFYTNGSL | 46 | Q9NPR9 | |
| AIGTFLFGAAASQSL | 101 | O14494 | |
| SFFLNYLADTQGGGS | 16 | Q86YN6 | |
| ANTGVFGFSFLLLTV | 71 | Q8IZM9 | |
| GLFAELNNSDSGLFT | 206 | Q8WTV0 | |
| LNNSDSGLFTVFTGV | 211 | Q8WTV0 | |
| NSFGAILQGSLFGLA | 151 | Q99808 | |
| DAATQIFFSLSLAFG | 256 | Q96N87 | |
| NFFSGVFVFSSLIGQ | 426 | Q9NQW8 | |
| EGSAQFAAQIFGLSN | 381 | P22234 | |
| FAQFSQEIGLASLGA | 286 | P17752 | |
| DTSLFFGTAATGFQQ | 676 | P98169 | |
| TLVQFGGFLASNLST | 776 | Q8NI27 | |
| EGSFFSAFLNLLVSA | 101 | Q6ZVK1 | |
| STVNRFLGLASFFAG | 421 | O15374 | |
| GNQEFIAFGISNIFS | 381 | O43511 | |
| GNTFFDAGAAEFLTS | 181 | Q8WU10 | |
| LSFFDFSGLTLDGAL | 351 | Q9BQI7 | |
| NSGTSFVAGFAIFSI | 321 | Q9NSD5 | |
| LNSFSAFGNSFNLTG | 1721 | Q92545 | |
| AFGNSFNLTGEVFSK | 1726 | Q92545 | |
| ASGFDFSQVLALSGA | 81 | O75191 | |
| ENFQLGAFLGSFVSI | 296 | Q86UB9 | |
| QALNNLQSTFSGFGF | 231 | P35250 | |
| LQSTFSGFGFINSEN | 236 | P35250 | |
| DSSALTGGFQTFNFK | 416 | Q6UXZ4 | |
| TAFFGTGNIASINSF | 796 | O95427 | |
| FALFLGASSENAGTL | 1531 | P27708 | |
| LLGNISSIAFFNFAG | 266 | Q8N357 | |
| GSLFASENFLGISSQ | 396 | Q8IWR0 | |
| LDTSLFFGTAATGFQ | 671 | P98168 | |
| FFGTAATGFQQSSLN | 676 | P98168 | |
| LLGSFQLFQSFPTFG | 511 | Q8WU66 | |
| TNFQALAAEFGGESF | 181 | Q6NUS6 | |
| GLFSQKSFLVLGFSN | 551 | Q92547 | |
| SGALGTRGTFNFSQF | 486 | P01266 | |
| AGFFFSELAGLDASQ | 41 | Q6UXP3 | |
| QGTSFTFGGLNQARF | 166 | Q13508 |